In summary, our study established a functional role of FTO during the fasting–feeding cycle and in the pathogenesis of NAFLD, which responded to insulin and promoted hepatic lipogenesis by stabilizing SREBF1 and ChREBP mRNAs. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.